Cambridge Cognition 

€0.3140
10
+€0.00+0%星期五 19:47

統計

當日最高
-
當日最低
-
52週高點
0.53
52週低點
0.276
成交量
-
平均成交量
8
市值
14.64M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

9月16日預期
Q2 2025
Q1 2026
Q2 2026
-0.03
-0.02
-0.01
-0.01
預期EPS
不適用
實際EPS
-0.01848980304

財務

-17.86%利潤率
未盈利
2020
2021
2022
2023
2024
2025
10.86M營收
-1.94M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 1M7.STU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cambridge Cognition Holdings Plc is a neuroscience technology company focused on developing and globally marketing sophisticated cognitive testing solutions for use in clinical settings. The firm operates internationally, serving clients in the United States, United Kingdom, and European Union, among other regions. Its extensive product portfolio includes CANTAB Recruit, an online platform designed to help pharmaceutical and biotechnology companies efficiently identify and onboard eligible participants for clinical trials, particularly in high-need therapeutic areas such as Alzheimer's disease. For broader pharmaceutical research, CANTAB Connect offers digital cognitive assessment tools applicable across all clinical trial phases (I-IV) and various medical fields. Additionally, the Cognition Kit is a digital health platform that utilizes wearable and smartphone applications to collect data, aiming to boost patient involvement, validate treatment efficacy, and deepen understanding of diseases and individual responses to medication. Other specialized offerings include CANTAB Connect Research, advanced software providing precise digital metrics for cognitive function in brain research; CANTAB Mobile, a touchscreen memory test frequently used in clinical studies pertaining to Alzheimer's disease; and CANTAB BrainHealth, an online digital assessment tool for monitoring mental well-being and cognitive performance in professional environments. The company also provides CANTAB Insight, a medical device for evaluating an individual's cognitive health, and NeuroVocalix, a secure platform enabling automated administration and scoring of validated verbal cognitive assessments. Beyond its technological products, Cambridge Cognition furnishes a suite of expert consultancy and operational management services tailored to enhance clinical trials and cognitive research. These services encompass neuroscience and technical advice, study design, data analysis, comprehensive study and data management, and the provision of insightful reports and interpretations. Cambridge Cognition Holdings Plc was established in 2012 and is headquartered in Cambridge, United Kingdom.
顯示更多
執行長
Robert Baker
員工
74
國家
英國
ISIN
GB00B8DV9647
WKN
000A1T9LW

上市

0 則留言

分享你的想法

常見問題

Cambridge Cognition 今天的股價是多少?▼
1M7.STU 目前價格為 €0.31 EUR,過去 24 小時上漲了 +0%。在圖表上更密切關注 Cambridge Cognition 股價表現。
Cambridge Cognition 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Stuttgart 交易所,Cambridge Cognition 的股票以代號 1M7.STU 進行交易。
Cambridge Cognition 的股價在上漲嗎?▼
1M7.STU 股票較上週上漲 +0.64%,本月下跌 -7.65%,過去一年 Cambridge Cognition 下跌 -14.21%。
Cambridge Cognition 的市值是多少?▼
今天 Cambridge Cognition 的市值為 14.64M
Cambridge Cognition 下一次財報日期是什麼時候?▼
Cambridge Cognition 將於 2027年5月5日 公布下一次財報。
Cambridge Cognition 上一季度的財報如何?▼
1M7.STU 上一季度的財報為每股 -0.02 EUR,預估為 不適用 EUR,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Cambridge Cognition 去年的營收是多少?▼
Cambridge Cognition 去年的營收為 10.86MEUR。
Cambridge Cognition 去年的淨利是多少?▼
1M7.STU 去年的淨收益為 -1.94MEUR。
Cambridge Cognition 有多少名員工?▼
截至 2026年11月2日,公司共有 74 名員工。
Cambridge Cognition 位於哪個產業?▼
Cambridge Cognition從事於Health & Wellness產業。
Cambridge Cognition 何時完成拆股?▼
Cambridge Cognition 最近沒有進行任何拆股。
Cambridge Cognition 的總部在哪裡?▼
Cambridge Cognition 的總部位於 英國 的 Cambridge。